FDA Clearance Tracker · P990086-S004
HEALTHTRONICS OSSATRON
Last checked: Nov 20, 2026Latest source record: Aug 6, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Aug 6, 2004
Approved
Time to decision
179 days
Received Feb 9, 2004. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P990086-S004
- Device name
- HEALTHTRONICS OSSATRON
- Applicant
- Sanuwave, Inc.
- Applicant location
- Alpharetta, GA
- Received
- Feb 9, 2004
- Decided
- Aug 6, 2004
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P990086
Device type
- Device type
- Generator, shock-wave, for pain relief (NBN)
- Device class
- Class III
- Specialty
- Physical Medicine & Rehabilitation
FDA's approval statement
As written in FDA's record.
APPROVAL FOR INSERTION OF A TABLE OF ADVERSE EVENTS AND A BRIEF PARAGRAPH FOLLOWING THE POST-APPROVAL STUDY OF ESW TREATMENT OF PLANTAR FASCIITIS CONSTITUTING THE LABELING CHANGES IN THE OPERATING MANUAL.
Source documents
Other decisions for Sanuwave, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- dermaPACE SystemNew device typeDe Novo
DEN160037 · Decided Dec 28, 2017 · 521 days after receipt
Device type: Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers (PZL) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.